跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31 条关于
“IFLI”
全部
31
临床试验
21
药物
0
机构
0
资讯
10
去年
CIT Therapeutics Secures $2.5M Partnership with IFLI to Advance Novel SUMOylation-Targeted Cancer Therapy
去年
Verismo Therapeutics Advances KIR-CAR Platform with HLB Innovation Merger and IFLI Partnership
去年
Innate Pharma and IFLI Partner to Advance IPH6501 in Follicular Lymphoma
7个月前
Enterome Strengthens Board with BeiGene's Former CMO as OncoMimics Platform Shows Promise in Cancer Trials
去年
Novel BAFF-R CAR-T Therapy Achieves Complete Response in Heavily Pretreated Follicular Lymphoma Patient
去年
PeproMene Bio Secures $11 Million Investment to Advance BAFF-R CAR T-Cell Therapy for Follicular Lymphoma
去年
Enterome Secures $19 Million to Advance Novel OncoMimics Immunotherapy for Indolent Non-Hodgkin Lymphoma
10天前
PeproMene Bio's BAFF-R CAR T-Cell Therapy Shows 80% Complete Response Rate in Relapsed/Refractory B-Cell Lymphomas
9天前
Lancet Publishes Phase 1 Data for PeproMene's BAFF-R CAR T: 80% Complete Response, Grade 1-Only Toxicity
去年
Innate Pharma Unveils Growth Strategy and Highlights Clinical Trial Progress